- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03188302
Evaluation of New Method for Measuring Stool Consistency
Evaluation of a New Method for Measuring Stool Consistency, Using a Texture Analyser (TA.XT Express Texture Analyser)
Study Overview
Detailed Description
It is now obvious that the proper functioning of the gastrointestinal tract has a positive effect on the quality of life. Normal bowel habits vary considerably from person to person with regard to frequency of bowel movements, and bulk and consistency of stools. Constipation is the common digestive complaint in European populations, and softening stool consistency can be regarded as beneficial for such population in terms of reducing incidence of hard or lumpy stools .
The Bristol Stool Form Scale (BS) is validated as a surrogate measure for gastrointestinal transit time, and has been also applied to an evaluation of stool consistency. Subjects compare their stool with the BS chart consisting of seven categories and choose one score which has a nearest analog form. The BS has been widely used in the studies to evaluate changes in stool consistency after dietary intervention using probiotics and/or prebiotics. However, there is a lack of evidence in the validity of BS to yield consistent and reproducible estimates of changes in stool consistency over time. In order to obtain a closer estimate of its change, it would be preferred to use a more directly observable and objective parameter or combination of parameters.
From the above mentioned backgrounds, this study is conducted to validate a new direct method for the measurement of stool consistency, using Texture Analyser: TA.XTExpress Texture Analyser (Stable Micro Systems Ltd.).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aalst, Belgium, 9300
- Onze-Lieve-Vrouw Hospital Aalst
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Informed consent obtained before any study-related activities.
- Healthy female or male aged 18 years (inclusive) or older.
- Is willing and able to provide at least 3 stool samples during 2 collection periods of approximately 60 hours, to store the samples in appropriate conditions and to return the samples within the required timeframe.
- Is willing and able to complete a diary during the stool collection periods in order to collect information about form of the stools (based on the Bristol Stool Form Scale classification), bowel habit and sleep habit.
- Understands the Dutch or English language (reading, writing, speaking).
Exclusion Criteria:
- Language barrier, mental or legal incapacity, unwillingness or inability to understand or not being able to participate in this trial.
- Is treated (i.e., currently treated, treated within 1 month before inclusion) for constipation, diarrhoea or any other illness, by use of antibiotics or any other treatment with impact on defecation.
- Females of child bearing potential who are pregnant, breast-feeding or intend to become pregnant.
- Is unable to refrain from or anticipates the use of disallowed medications, e.g., antibiotics, laxatives, anti-diarrheal medication.
- Has any history of drug and/or alcohol abuse.
- Any clinically significant disease which in the Investigator's opinion could interfere with the safety of study participants or with the results of the study.
- Participation in another interventional clinical study or receipt of any investigational product within 1 month before visit 1.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Specimen collection
Collection of stool samples
|
The subjects collect stool samples to be used for validation of a new direct measurement of stool consistency.
Every stool sample produced during 2 collection periods of approximately 60 hours each have to be collected using the Commode Specimen Collection System (Medline Industries, Inc.).
Each collection period starts preferably in the evening (20h00) and ends 3 days later in the morning (08h00).
The collected samples must be stored at subject's home in a refrigerator provided by the sponsor until handover to the site staff.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stool consistency
Time Frame: Two stool collection periods of approximately 60 hours each
|
Stool consistency is measured as force (g) during compression by Texture Analyser.
A cylinder probe is put vertically into the object with a constant speed and the force is measured when reaching down to the target (5 mm down from the surface) as an outcome.
|
Two stool collection periods of approximately 60 hours each
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bristol Stool Form Scale score
Time Frame: Two stool collection periods of approximately 60 hours each
|
Bristol Stool Form Scale (BS) is for classifying the form of stool into 7 categories scored from 1 to 7; (1) Separate hard lumps like nuts (difficult to pass); (2) Sausage-shaped but lumpy; (3) Like a sausage but with cracks on its surface; (4) Like a sausage or snake, smooth and soft; (5) Soft blobs with clear-cut edges (passed easily); (6) Fluffy pieces with ragged edges, a mushy stool; (7) Watery, no solid pieces, entirely liquid.
Subjects choose one of the BS scores which has a nearest analog form with their stools at every defecation.
|
Two stool collection periods of approximately 60 hours each
|
|
Stool water content
Time Frame: Two stool collection periods of approximately 60 hours each
|
Percentage of water in stool (weight/weight %)
|
Two stool collection periods of approximately 60 hours each
|
|
Stool mucin
Time Frame: Two stool collection periods of approximately 60 hours each
|
Concentration of mucin in stool
|
Two stool collection periods of approximately 60 hours each
|
|
Stool pH
Time Frame: Two stool collection periods of approximately 60 hours each
|
Degree of stool pH
|
Two stool collection periods of approximately 60 hours each
|
|
Stool metabolites
Time Frame: Two stool collection periods of approximately 60 hours each
|
Concentrations of stool metabolites including organic acids
|
Two stool collection periods of approximately 60 hours each
|
|
Stool microbiota composition
Time Frame: Two stool collection periods of approximately 60 hours each
|
Relative abundance of microbiota species (% of total) in stool
|
Two stool collection periods of approximately 60 hours each
|
|
Stool amount
Time Frame: Two stool collection periods of approximately 60 hours each
|
Weight (g) of stool produced in each defecation
|
Two stool collection periods of approximately 60 hours each
|
|
Bowel habit
Time Frame: Two stool collection periods of approximately 60 hours each
|
Presence or absence of straining during evacuation, presence or absence of sensation of remaining stool in the rectum after evacuation
|
Two stool collection periods of approximately 60 hours each
|
|
Sleep habit
Time Frame: Two stool collection periods of approximately 60 hours each
|
Getting-up time, going-to-bed time and sleeping hours
|
Two stool collection periods of approximately 60 hours each
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Ignace Demeyer, Dr., Onze-Lieve-Vrouw Hospital Aalst
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- YHER16-TAXT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
RAGE BioRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Collection of stool samples
-
Assistance Publique - Hôpitaux de ParisUnité de Recherche Clinique Necker Cochin, FranceCompletedEnteropathy, Necrotizing EnterocolitisFrance
-
Centre Georges Francois LeclercEnteromeCompleted
-
Hospices Civils de LyonCompletedInflammatory Bowel DiseasesFrance
-
GlaxoSmithKlineCompletedInfections, RotavirusRomania
-
GlaxoSmithKlineCompletedRotavirus Severe GastroenteritisSingapore
-
OncoHost Ltd.RecruitingHealthy | Non Small Cell Lung CancerUnited States
-
Innovaderm Research Inc.RecruitingPlaque Psoriasis | Atopic Dermatitis | Hidradenitis Suppurativa | Palmoplantar Pustulosis | Acne | Chronic Hand EczemaCanada
-
University of PittsburghCompletedTransplantationUnited States
-
Sohag UniversityCompletedAcne Vulgaris | Helicobacter Pylori InfectionEgypt
-
University Hospital, Clermont-FerrandUnknown